Derivation Web

v0.1 · api
source · application/json

source_7e7aaec71bd54e73

sha256 6e16c4fd1aa652ccf8b5fef36c7630f6dc5259387c2ef6a44cc4b96031dc45ae

by researka:v2 · 2026-06-25 04:28:59.822816+04:00

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "825b123b-8868-470c-9e7e-9196adde37c5", "sources": [{"directness": "primary", "doi": "10.1016/j.ebiom.2023.104481", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability"}, {"directness": "primary", "doi": "10.3390/ph19030431", "risk_of_bias": "not appraised in public sidecar", "study": "The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke"}, {"directness": "primary", "doi": "10.1016/j.hrthm.2026.01.007", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic reduction of senescent cells mitigates atrial arrhythmia vulnerability in aging rabbits"}, {"directness": "primary", "doi": "10.1111/acel.70500", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic Treatment With Fisetin Reverses Age‐Related Endothelial Dysfunction Partially Mediated by SASP Factor CXCL12"}, {"directness": "primary", "doi": "10.1111/acel.13767", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age"}, {"directness": "primary", "doi": "10.1016/j.mtbio.2025.102741", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic-loaded asymmetric wound dressing for targeted senescent cell clearance in diabetic wound healing"}, {"directness": "primary", "doi": "10.1038/s43587-025-01057-z", "risk_of_bias": "not appraised in public sidecar", "study": "Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance"}, {"directness": "primary", "doi": "10.1186/s12951-026-04138-2", "risk_of_bias": "not appraised in public sidecar", "study": "Supramolecular delivery of senolytics enables targeted anti-senescence therapy and accelerated fracture healing"}, {"directness": "primary", "doi": "10.1038/s44319-026-00740-5", "risk_of_bias": "not appraised in public sidecar", "study": "Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigor"}, {"directness": "review-level", "doi": "10.1111/acel.13294", "risk_of_bias": "not appraised in public sidecar", "study": "Is exercise a senolytic medicine? A systematic review"}, {"directness": "primary", "doi": "10.1002/advs.202509263", "risk_of_bias": "not appraised in public sidecar", "study": "DEL‐1 is an Endogenous Senolytic Protein that Inhibits Senescence‐Associated Bone Loss"}, {"directness": "primary", "doi": "10.1038/s41413-026-00526-4", "risk_of_bias": "not appraised in public sidecar", "study": "Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice"}, {"directness": "primary", "doi": "10.1016/j.bioactmat.2025.11.047", "risk_of_bias": "not appraised in public sidecar", "study": "Synergistic targeting of senolytic and senomorphic action with dual-engineered biomimetic macrophage nanovesicles for mitigating osteoarthritis"}, {"directness": "primary", "doi": "10.4081/ejh.2026.4537", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytics alleviate cyclophosphamide-induced premature ovarian insufficiency by eliminating senescent cells"}, {"directness": "primary", "doi": "10.1111/acel.70358", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic‐Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers"}, {"directness": "primary", "doi": "10.3390/nu17040667", "risk_of_bias": "not appraised in public sidecar", "study": "Preliminary Data on the Senolytic Effects of Agrimonia pilosa Ledeb. Extract Containing Agrimols for Immunosenescence in Middle-Aged Humans: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Study"}, {"directness": "primary", "doi": "10.1111/acel.70345", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic Treatment With Dasatinib and Quercetin Reshapes Influenza‐Specific CD8 T Cell Responses During Infection in Aged, Vaccinated Mice"}, {"directness": "primary", "doi": "10.1038/s41591-024-03096-2", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial."}, {"directness": "primary", "doi": "10.1186/s13063-024-08474-2", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytics To slOw Progression of Sepsis (STOP-Sepsis) in elderly patients: Study protocol for a multicenter, randomized, adaptive allocation clinical trial"}, {"directness": "primary", "doi": "10.1186/s12967-026-08221-y", "risk_of_bias": "not appraised in public sidecar", "study": "Synergistic senolytic–regenerative therapy significantly extends healthspan and lifespan"}, {"directness": "primary", "doi": "10.1016/j.isci.2026.115607", "risk_of_bias": "not appraised in public sidecar", "study": "Natural senolytic activity of Rhodiola rosea extract alleviates age-associated phenotypes via paraptosis"}, {"directness": "primary", "doi": "10.14283/jpad.2021.62", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease (SToMP-AD): A Pilot Clinical Trial"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis"}, {"directness": "primary", "doi": "10.1111/acel.70480", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic Treatment Reduces Acute and Chronic Lung Inflammation in an Aged Mouse Model of Influenza"}, {"directness": "primary", "doi": "10.12688/f1000research.151963.2", "risk_of_bias": "not appraised in public sidecar", "study": "Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders"}, {"directness": "review-level", "doi": "10.18632/aging.205827", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic effects of exercise in human muscles require acute inflammation."}, {"directness": "review-level", "doi": "10.1101/2025.08.13.670216", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic treatment with fisetin reverses age-related endothelial dysfunction partially mediated by SASP factor CXCL12"}, {"directness": "primary", "doi": "10.1101/2023.12.12.571277", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic Intervention Improves Cognition, Metabolism, and Adiposity in Female APP NL-F/NL-F Mice"}, {"directness": "review-level", "doi": "10.1038/s41591-023-02543-w", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial."}, {"directness": "review-level", "doi": "10.1101/2025.08.27.672709", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers"}, {"directness": "primary", "doi": "10.1101/2024.05.22.595355", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of senolytic drugs in young female mice chemically induced to estropause"}, {"directness": "primary", "doi": "10.3389/fneur.2023.1271941", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease"}, {"directness": "primary", "doi": "10.1016/j.ebiom.2018.12.052", "risk_of_bias": "not appraised in public sidecar", "study": "Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Natural Senolytic 2024"}]}
metadata
{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "825b123b-8868-470c-9e7e-9196adde37c5",
  "researka_submission_id": "ea11f591-877d-4c3b-a36d-280dd5de2f5b",
  "sidecar_name": "risk_of_bias.json",
  "sidecar_url": "https://api.researka.org/publications/825b123b-8868-470c-9e7e-9196adde37c5/sidecars/risk_of_bias.json"
}

view full chain →